MBXIX
Price
$38.05
Change
+$0.08 (+0.21%)
Updated
Jun 5 closing price
Net Assets
8.03B
PBAIX
Price
$15.36
Change
+$0.02 (+0.13%)
Updated
Jun 5 closing price
Net Assets
3.04B
Interact to see
Advertisement

MBXIX vs PBAIX

Header iconMBXIX vs PBAIX Comparison
Open Charts MBXIX vs PBAIXBanner chart's image
Catalyst/Millburn Hedge Strategy I
Price$38.05
Change+$0.08 (+0.21%)
VolumeN/A
Net Assets8.03B
BlackRock Tactical Opportunities Instl
Price$15.36
Change+$0.02 (+0.13%)
VolumeN/A
Net Assets3.04B
MBXIX vs PBAIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MBXIX vs. PBAIX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBXIX is a Buy and PBAIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MBXIX has more cash in the bank: 8.03B vs. PBAIX (3.04B). MBXIX pays higher dividends than PBAIX: MBXIX (1.92) vs PBAIX (0.00). MBXIX was incepted earlier than PBAIX: MBXIX (9 years) vs PBAIX (32 years). MBXIX (2.03) is less costly to investors than PBAIX (0.82). PBAIX is a more actively managed with annual turnover of: 146.00 vs. MBXIX (48.00). MBXIX has a lower initial minimum investment than PBAIX: MBXIX (2500) vs PBAIX (2000000). PBAIX annual gain was more profitable for investors over the last year : 8.41 vs. MBXIX (-0.99). MBXIX return over 5 years is better than : 52.64 vs. PBAIX (26.71).
MBXIXPBAIXMBXIX / PBAIX
Total Expense Ratio2.030.82248%
Annual Report Gross Expense Ratio2.030.82248%
Fund Existence9 years32 years-
Gain YTD-2.1903.300-66%
Front LoadN/AN/A-
Min. Initial Investment250020000000%
Min. Initial Investment IRAN/AN/A-
Net Assets8.03B3.04B264%
Annual Yield % from dividends1.920.00-
Returns for 1 year-0.998.41-12%
Returns for 3 years7.8721.8736%
Returns for 5 years52.6426.71197%
Returns for 10 yearsN/A33.36-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SHPAX18.99N/A
N/A
Saratoga Health & Biotechnology A
GSMGX13.59N/A
N/A
Goldman Sachs Small/Mid Cap Growth C
JLCYX69.59N/A
N/A
JHancock Fundamental Large Cap Core R2
BPIRX14.18N/A
N/A
Boston Partners Long/Short Rsrch Instl
REQCX41.54-0.09
-0.22%
Russell Sustnbl Aware Eq C